Reproxalap ophthalmic solution 0.25% reached the primary endpoint in a second phase 3 dry eye chamber trial, according to Aldeyra Therapeutics.

The global burden of atopic dermatitis (AD) in older adults is considerable and is expected to continue increasing to 2050.

The US Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a professor at the University of California-San Francisco, to lead its Center for Biologics Evaluation and Research.

HealthDay News — Boosting physical activity in midlife may improve brain health, according to a study published online April 30 in Alzheimer’s & Dementia.

For high school athletes, attention-deficit/hyperactivity disorder (ADHD) status, female sex, and younger age are potential risk factors for prolonged recovery from sport-related concussion.

Treatment with cyclosporine A 0.1% can reduce ocular surface temperature in patients with dry eye disease and meibomian gland ...

Preservative free cyclosporine is safe and effective for treating mild to moderate dry eye disease, a study shows.

Most Americans surveyed said they do not support the Trump administration’s recent cuts to staff and spending at federal health agencies.

The effectivity of orthokeratology lenses may be dependent upon a number of nonsynonymous variants in retinal disease-related gene sets.